Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Head and Neck Cancers
•
Radiation Oncology
What features would make you consider covering elective nodes in a locally advanced, node negative paranasal sinus SCC?
Is there strong evidence to guide this decision?
Answer from: Radiation Oncologist at Academic Institution
Yes if >/= T3 or for max sinus involvement.
Sign in or Register to read more
2902
Related Questions
In light of the recent publication in the JCO, how do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?
What are magic mouthwash alternatives that you would recommend?
How do you approach patients with SMARCB1 deficient sinonasal carcinoma for immunotherapy?
What dose are you routinely using for adjuvant RT for intermediate risk p16+ SCC of the OPX s/p TORS?
Do you have a preference between using 2 dose levels (5940/6996) versus 3 dose levels (5700/6300/6996) for NPC, EBV+ and why?
Is there a role for bromhexine for thick secretions during/after head and neck RT?
Would you offer radiation therapy for a 59 year old female patient with orbital sarcoidosis and no other site of disease who can no longer tolerate systemic therapy?
In a patient with bilateral neck level II small cell carcinoma with no apparent primary after workup with plans to receive concurrent cisplatin/etoposide, what would be your treatment volumes?
How do you approach patients with node positive sebaceous cell carcinoma of the eyelid for adjuvant chemotherapy and radiation?
When treating sinonasal undifferentiated carcinoma (SNUC) with induction chemotherapy followed by definitive chemoradiation, do you include the entire pre-chemo volume in your high-dose CTV?